The role of secondary bile acids in neoplastic development in the oesophagus

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 337-342

  Cronin, James ^a   Williams, Lisa ^b   McAdam, Elizabeth ^a   Eltahir, Zak ^a   Griffiths, Paul ^c   Baxter, John ^c   Jenkins, Gareth ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Barrett's metaplasia; Bile acid; DNA damage; Nuclear factor B signalling; Reflux

Indexed keywords

ASCORBIC ACID; BILE ACID; DEOXYCHOLIC ACID; EPIGALLOCATECHIN; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RESVERATROL; URSODEOXYCHOLIC ACID;

ANTIOXIDANT ACTIVITY; BARRETT METAPLASIA; CELL SURVIVAL; CHEMOPROPHYLAXIS; CHOLESTASIS; CYTOSOL; DNA DAMAGE; ENZYME ACTIVITY; ESOPHAGUS CANCER; GALLSTONE; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BARRETT ESOPHAGUS; BIOLOGICAL MODEL; CELL TRANSFORMATION; DRUG EFFECT; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; MODELS, BIOLOGICAL;

EID: 77953234603     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380337     Document Type: Review

References (38)

1. Phillips, R.W. and Wong, R.K. (1991) Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol. Clin. North Am. 20, 791-816
2. Prach, A.T., MacDonald, T.A., Hopwood, D.A. and Johnston, D.A. (1997) Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 350, 933
3. Ronkainen, J., Aro, P., Storskrubb, T., Johansson, S.E., Lind, T., Bolling-Sternevald, E., Vieth, M., Stolte, M., Talley, N.J. and Agréus, L. (2005) Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825-1831
4. Pohl, H. and Welch, H.G. (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl. Cancer Inst. 97, 142-146
5. Reference deleted
6. Attwood, S.E., Smyrk, T.C., DeMeester, T.R., Mirvish, S.S., Stein, H.J. and Hinder, R.A. (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111, 503-510
7. Ireland, A.P., Peters, J.H., Smyrk, T.C., DeMeester, T.R., Clark, G.W., Mirvish, S.S. and Adrian, T.E. (1996) Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann. Surg. 224, 358-370
8. Fein, M., Peters, J.H., Chandrasoma, P., Ireland, A.P., Oberg, S., Ritter, M.P., Bremner, C.G., Hagen, J.A. and DeMeester, T.R. (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J. Gastrointest. Surg. 2, 260-268
9. Gotley, D.C., Morgan, A.P. and Cooper, M.J. (1988) Bile-acid concentrations in the refluxate of patients with reflux esophagitis. Br. J. Surg. 75, 587-590
10. Kauer, W.K., Peters, J.H., DeMeester, T.R., Feussner, H., Ireland, A.P., Stein, H.J. and Siewert, R.J. (1997) Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 122, 874-881
11. Nehra, D., Howell, P., Williams, C.P., Pye, J.K. and Beynon, J. (1999) Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44, 598-602
12. Darragh, J., Hunter, M., Pohler, E., Nelson, L., Dillon, J.F., Nenutil, R., Vojtesek, B., Ross, P.E., Kernohan, N. and Hupp, T.R. (2006) The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injury. FEBS J. 273, 1930-1947
13. Kauer, W.K.H., Peters, J.H., DeMeester, T.R., Ireland, A.P., Bremner, C.G. and Hagen, J.A. (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone: the need for surgical therapy re-emphasized. Ann. Surg. 222, 525-531
14. Dvorak, K., Watts, G., Ramsey, L., Holubec, H., Payne, C., Bernstein, C., Jenkins, G., Sampliner, R., Prasad, A., Garewal, H. and Bernstein, H. (2009) Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am. J. Gastroenterol. 104, 302-309
15. Glinghammar, B., Inoue, H. and Rafter, J.J. (2002) Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-κB and AP-1. Carcinogenesis 23, 839-845
16. Powolny, A., Xu, J. and Loo, G. (2001) Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int. J. Biochem. Cell Biol. 33, 193-203
17. Greetham, H.L., Bingham, S.A. and Burns, P.A. (2007) Adduction of human p53 gene by fecal water: an in vitro biomarker of mutagenesis in the human large bowel. Cancer Epidemiol. Biomarkers Prev. 16, 2681-2685
18. Dvorak, K., Payne, C.M., Chavarria, M., Ramsey, L., Dvorakova, B., Bernstein, H., Holubec, H., Sampliner, R.E., Guy, N., Condon, A. et al. (2007) Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56, 763-771
19. Feagins, L.A., Zhang, H.Y., Zhang, X., Hormi-Carver, K., Thomas, T., Terada, L.S., Spechler, S.J. and Souza, R.F. (2008) Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G411-G417
20. Jolly, A.J., Wild, C.P. and Hardie, L.J. (2004) Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 19, 319-324
21. Jolly, A.J., Wild, C.P. and Hardie, L.J. (2009) Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells, Free Radical Res. 43: 234-240
22. Clemons, N.J., McColl, K.E.L. and Fitzgerald, R.C. (2007) Nitric oxide and acid induce double strand breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology 133, 1198-1209
23. Jenkins, G.J.S., D'Souza, F.R., Suzen, H.S., Eltahir, Z.S., James, S.A., Parry, J.M., Griffiths, A.P. and Baxter, J.N. (2007) Deoxycholic acid (DCA) at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of antioxidants in Barrett's oesophagus. Carcinogenesis 28, 136-142
24. Palmeira, C.M. and Rolo, A.P. (2004) Mitochondrially-mediated toxicity of bile acids. Toxicology 203, 1-15
25. Payne, C.M., Crowley, C., Washo-Stultz, D., Brielle, M., Bernstein, H., Bernstein, C., Beard, S., Holubec, H. and Warneke, J. (1998) The stress-response proteins poly(ADP-ribose) polymerase and NF-κB protect against bile salt-induced apoptosis. Cell Death Differ, 5,623-636
26. Washo-Stultz, D., Crowley-Weber, C.L., Dvorakova, K., Bernstein, C., Bernstein, H., Kunke, K., Waltmire, C.N., Garewal, H. and Payne, C.M. (2002) Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate induced apoptosis. Cancer Lett. 177, 129-144
27. Muhlbauer, M., Allard, B., Bosserhoff, A.K., Kiessling, S., Herfarth, H., Rogler, G., Scholmerich, J., Jobin, C. and Hellerbrand, C. (2004) Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-κB signal transduction and IL-8 gene expression in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G1000-G1008
28. Hellerbrand, C., Hoeger, S., Muelbauer, M., Thasler, W., Lock, G. and Schoelmerich, J. (2000) Bile acids induce proinflammatory cytokine expression in activated hepatic stellate cells via NFκB activation. Hepatology 32, A201
29. Jenkins, G.J.S., Harries, K., Doak, S.H., Wilmes, A., Griffiths, A.P., Baxter, J.N. and Parry, J.M. (2004) The bile acid deoxycholic acid at neutral pH activates NFκB and causes upregulation of IL-8. Carcinogenesis 25, 317-323
30. Abdel-Latif, M.M., O'Riordan, J. and Windle, H.J. (2004) NF-κB activation in esophageal adenocarcinoma. Relationship to Barrett's metaplasia, survival and response to neoadjuvant chemotherapy. Ann. Surg. 239, 491-500
31. Yoshida, N., Imamoto, E., Uchiyama, K., Kuroda, M., Naito, Y., Mukaida, N., Kawabe, A., Shimada, Y., Yoshikawa, T. and Okanoue, T. (2006) Molecular mechanisms involved in interleukin 8 production by normal human oesophageal epithelial cells. Aliment. Pharmacol. Ther. 24, 219-226
32. Wu, J., Gong, J., Geng, J. and Song, Y. (2008) Deoxycholic acid induces the overexpression of intestinal mucin MUC2 via NF-κB signalling pathway in human esophageal adenocarcinoma cells. BMC Cancer 8, 333
33. Kazumori, H., Ishihara, S. and Kinoshita, Y. (2009) Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut 58, 620-628
34. Terry, P., Lagergren, J., Ye, W., Nyren, O. and Wolk, A. (2000) Antioxidants and cancers of the esophagus and gastric cardia. Int. J. Cancer 87, 750-754 (Pubitemid 30620420)
35. Jenkins, G.J.S., Cronin, J., Alhamdani, A., Rawat, N., D'Souza, F., Thomas, T., Eltahir, Z., Griffiths, A.P. and Baxter, J.N. (2008) The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-κB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis 23, 399-405
36. Rosignoli, P., Fabiani, R., Bartolomeo, A., Fuccelli, R., Pelli, M.A. and Moozzi, G. (2008) Genotoxic effect of bile acids on human normal and tumour cells and protection by dietary antioxidants and butyrate. Eur. J. Cancer 47, 301-309
37. Shah, S.S., Volkov, Y., Arfin, Q., Abdel-Latif, M.M. and Kelleher, D. (2006) Ursodeoxycholic acid inhibits interleukin β1 and deoxycholic acid induced activation of NF-κB and AP-1. Int. J. Cancer 118, 532-539
38. Song, S., Guha, S., Liu, K., Buttar, N.S. and Bresalier, R.S. (2007) COX-2 induction by unconjugated bile acids involves reactive oxygen species mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56, 1512-1521